Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Shares withheld for taxes Chairman gave up 2,659 shares (to pay taxes)
  2. 4 Exercise or conversion President & CEO acquired 3,662 shares (option exercise)
  3. 4/A Open-market sale EVP, Corporate Services Divisi sold 43,572 shares at an average $35.56 ($1,549,595)
  4. 4 Open-market sale Director sold 19,424 shares at $29.78 ($578,425)
  5. 4 Open-market sale EVP, Biodefense Divison sold 8,438 shares at $29.75 ($251,001)
  6. 4 Open-market sale President and CEO sold 28,240 shares at $31.28 ($883,296)
  7. 4 Open-market sale Director sold 5,900 shares at an average $34.09 ($201,107)
  8. 4 Grant or award Director acquired 14,226 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4/A Other disposition 10% owner disposed of 20,229,849 shares (other)
  11. 4 Other disposition 10% owner disposed of 20,230,074 shares (other)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market sale Director sold 4,700 shares at $44.12 ($207,364)
  14. 4 Open-market sale President & CEO sold 8,699 shares at $43.74 ($380,494)
  15. 4 Open-market sale Chairman sold 9,835 shares at $43.50 ($427,823)
  16. 4 Open-market sale Director sold 27,867 shares at an average $42.33 ($1,179,511)
  17. 4 Open-market sale Chairman sold 39,759 shares at an average $43.13 ($1,714,760)
  18. 4 Open-market sale Chairman sold 85,000 shares at an average $42.52 ($3,614,300)
  19. 4 Open-market sale President & CEO sold 8,701 shares at $42.00 ($365,442)
  20. 4 Grant or award Director acquired 5,985 shares (grant or award)

Page 23 of 49 · 970 filings